The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Cardiovascular disease in persons with depressive and anxiety disorders
Open accessAbstract
Background Associations between depression, and possibly anxiety, with cardiovascular disease have been established in the general population and among heart patients. This study examined whether cardiovascular disease was more prevalent among a large cohort of depressed and/or anxious persons. In addition, the role of specific clinical characteristics of depressive and anxiety disorders in the association with cardiovascular disease was explored. Methods Baseline data from the Netherlands Study of Depression and Anxiety were used, including persons with a current (i.e. past year) or remitted DSM-IV depressive or anxiety disorder (N=2315) and healthy controls (N=492). Additional clinical characteristics (subtype, duration, severity, psychoactive medication) were assessed. Cardiovascular disease (stroke and coronary heart disease) was assessed using algorithms based on self-report and medication use. Results Persons with current anxiety disorders showed an about three-fold increased prevalence of coronary heart disease (OR anxiety only=2.70, 95%CI=1.31–5.56; OR comorbid anxiety/depression=3.54, 95%CI=1.79–6.98). No associations were found for persons with depressive disorders only or remitted disorders, nor for stroke. Severity of depressive and anxiety symptoms - but no other clinical characteristics - most strongly indicated increased prevalence of coronary heart disease. Limitations Cross-sectional design. Conclusions Within this large psychopathology-based cohort study, prevalence of coronary heart disease was especially increased among persons with anxiety disorders. Increased prevalence of coronary heart disease among depressed persons was largely owing to comorbid anxiety. Anxiety - alone as well as comorbid to depressive disorders - as risk indicator of coronary heart disease deserves more attention in both research and clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386 · cited 3×
“…cardiovascular event or death (Barth et al., 2004; Nicholsonet al., 2006;vanMelle et al., 2004),while in thegeneral population depression increases risk of cardiovascular disease (CVD) about 1.6 to 1.8 times (Nicholson et al., 2006;Rugulies, 2002;Van der Kooy et al., 2007;Wulsin and Singal, 2003).”
InfluentialThe Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358
Depression as a predictor for coronary heart disease
Rugulies, R. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00439-7 · Cited by 1,110
Suls, J., & Bunde, J. (2005) · Psychological Bulletin · doi:10.1037/0033-2909.131.2.260 · Cited by 878
Frasure-Smith, N., & Lespérance, F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.4 · Cited by 571
Comparing self-reported and physician-reported medical history
Kehoe, R., Wu, S.-Y., Leske, M. C., & Chylack, L. T. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117078 · Cited by 441
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“and related disorders including cardiovascular diseases, gastrointestinal diseases, arthritis, respiratory diseases such as asthma, thyroid disease, migraine headaches, back pain, and allergic conditions [16,52,1430-1432].”
BackgroundAnxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis
Chalmers, J. A., Quintana, D. S., Abbott, M. J.-A., & Kemp, A. H. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00080 · Cited by 1,067
“Anxiety disorders also increase risk of cardiovascular disease (CVD) three- to fourfold, after accounting for sex, substance use,and depression (3,4) while risk of cardiac mortality is increased twofold (5–7).”
BackgroundKemp, A. H., & Quintana, D. S. (2013) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2013.06.018 · Cited by 538
Atlantis, E., & Sullivan, T. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02709.x · Cited by 472
Anxiety disorders and inflammation in a large adult cohort
Vogelzangs, N., Beekman, A. T. F., de Jonge, P., & Penninx, B. W. J. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.27 · Cited by 458
“In addition, several disease-related covariates were taken into account including the presence of cardiovascular disease (assessed by selfreport supported by appropriate medication use (see Vogelzangs et al.(6) for detailed description)), the presence of diabetes (fasting plasma glucose level X7.”
BackgroundMethodSelf-citationKemp, A. H., Quintana, D. S., Felmingham, K. L., Matthews, S., & Jelinek, H. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030777 · Cited by 447
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00422 · Cited by 437
Vogelzangs, N., Duivis, H. E., Beekman, A. T. F., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J. H., de Jonge, P., & Penninx, B. W. J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.8 · Cited by 323
“25 for detailed description), presence of diabetes (fasting plasma glucose level X 7.0 mmoll (cid:2) 1 or use of anti-diabetic medication (A10)), and the number of other self-reported chronic diseases for which persons received treatment (including lung disease, osteoarthritis or rheumatic disease,…”
BackgroundInfluentialSelf-citationDuivis, H. E., Vogelzangs, N., Kupper, N., de Jonge, P., & Penninx, B. W. J. H. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.01.002 · Cited by 282
Self-citationTully, P. J., Cosh, S. M., & Baune, B. T. (2013) · Psychology, Health & Medicine · doi:10.1080/13548506.2012.749355 · Cited by 230
Prather, A. A., Vogelzangs, N., & Penninx, B. W. J. H. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.018 · Cited by 181
Self-citationMeta-analysis: Aerobic exercise for the treatment of anxiety disorders
Bartley, C. A., Hay, M., & Bloch, M. H. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.016 · Cited by 158
Alvares, G. A., Quintana, D. S., Kemp, A. H., Van Zwieten, A., Balleine, B. W., Hickie, I. B., & Guastella, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070468 · Cited by 154
“It has been suggested that dysregulated autonomic nervous system (ANS) activity [2] may underlie this three-fold increase in risk for CVD [3] in anxiety.”
BackgroundInfluentialHealth-related quality of life, depression, and anxiety in patients with autoimmune hepatitis
Schramm, C., Wahl, I., Weiler-Normann, C., Voigt, K., Wiegard, C., Glaubke, C., Brähler, E., Löwe, B., Lohse, A. W., & Rose, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.035 · Cited by 128
Depression, anxiety, and arterial stiffness
Seldenrijk, A., van Hout, H. P. J., van Marwijk, H. W. J., de Groot, E., Gort, J., Rustemeijer, C., Diamant, M., & Penninx, B. W. J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.034 · Cited by 101
Self-citationChalmers, J. A., Heathers, J. A. J., Abbott, M. J., Kemp, A. H., & Quintana, D. S. (2016) · BMC Psychology · doi:10.1186/s40359-016-0138-z · Cited by 102
Canivet, C., Nilsson, P. M., Lindeberg, S. I., Karasek, R., & Östergren, P.-O. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.02.001 · Cited by 78
Rudolf, S., Greggersen, W., Kahl, K. G., Hüppe, M., & Schweiger, U. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.02.016 · Cited by 71
Ghezzi, E. S., Sharman, R. L. S., Selvanayagam, J. B., Psaltis, P. J., Sanders, P., Astley, J. M., Knayfati, S., Batra, V., & Keage, H. A. D. (2023) · Europace · doi:10.1093/europace/euad130 · Cited by 73
Atlantis, E., Vogelzangs, N., Cashman, K., & Penninx, B. J. W. H. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70006-x · Cited by 51
Self-citationSavolainen, K., Räikkönen, K., Kananen, L., Kajantie, E., Hovatta, I., Lahti, M., Lahti, J., Pesonen, A.-K., Heinonen, K., & Eriksson, J. G. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.07.005 · Cited by 40
Comprehensive review of generalized anxiety disorder in primary care in Europe.
Parmentier, H., García-Campayo, J., & Prieto, R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.770731 · Cited by 37
Rahbar Karbasdehi, E., Abolghasemi, A., & Rahbar Karbasdehi, F. (2018) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-018-9390-2 · Cited by 7
Metadata
- Authors
- Vogelzangs, N., Seldenrijk, A., Beekman, A. T. F., van Hout, H. P. J., de Jonge, P., & Penninx, B. W. J. H.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 125
- Issue
- 1-3
- Pages
- 241-248
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2139938405
- Cited by
- 180
- References
- 8
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.